[{
  "active": true,
  "name": "Rules-Test2",
  "date_created": "2016-06-24T15:38:31+00:00",
  "version": "2015-08-06",
  "stratum_id": "100",
  "description": "This TA is used by Cuke Test",
  "target_id": "113",
  "target_name": "Crizotinib",
  "func_gene": "ALK",
  "treatment_arm_status": "OPEN",
  "study_id": "APEC1621",
  "assay_rules": [],
  "num_patients_assigned": null,
  "date_opened": null,
  "treatment_arm_drugs": [{
    "name": "Crizotinib",
    "pathway": "ALK",
    "drug_id": "113"
  }],
  "snv_indels": [],

  "non_hotspot_rules": [{
    "inclusion": true,
    "oncomine_variant_class": "deleterious",
    "public_med_ids": [],
    "func_gene": "PTEN",
    "arm_specific": "false",
    "level_of_evidence": 3.0,
    "function": null,
    "protein_match": null,
    "type": "nhr",
    "exon": null
  }],
  "copy_number_variants": [],
  "gene_fusions": [{
    "ocp_reference": "A",
    "gene_name": "ALK",
    "identifier": "TPM3-ALK.T7A20",
    "inclusion": false,
    "public_med_ids": ["23724913"],
    "arm_specific": false,
    "level_of_evidence": 2.0,
    "chromosome": "chr2",
    "ocp_alternative": "[chr1:154142875[A",
    "description": "ALK translocation",
    "position": "29446394",
    "type": "gf"
  }, {
    "ocp_reference": "C",
    "gene_name": "FGFR2",
    "identifier": "FGFR2-OFD1.F17O3",
    "inclusion": false,
    "public_med_ids": [],
    "arm_specific": false,
    "level_of_evidence": 3.0,
    "chromosome": "chr10",
    "ocp_alternative": "C[chrX:13754596[",
    "description": "some description",
    "position": "123243211",
    "type": "gf"
  }],
  "exclusion_diseases": [{
    "disease_code_type":"ICD-O",
    "disease_code": "10058354",
    "disease_name": "Bronchioloalveolar carcinoma",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "10025032",
    "ctep_sub_category": null,
    "disease_name": "Lung adenocarcinoma",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "90600324",
    "disease_name": "Lung adenocar. w/ bronch. feat.",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "10029514",
    "disease_name": "Non-small cell lung cancer, NOS",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "10025125",
    "disease_name": "Squamous cell lung carcinoma",
    "exclusion":true
  },
    {
      "disease_code_type":"ICD-O",
      "disease_code": "10033701",
      "disease_name": "Papillary thyroid carcinoma",
      "exclusion":false
    }],
  "exclusion_drugs": [{
    "name": "Doxorubicin Hydrochloride",
    "drug_id": "10001",
    "drug_class": "ALK inhibitor",
    "target": "ALK"
  }],
  "status_log": [],
  "current_patients": "0.0",
  "former_patients": "0.0",
  "not_enrolled_patients": "0.0",
  "pending_patients": "0.0"
}, {
  "active": true,
  "name": "Rules-Test1",
  "date_created": "2016-06-24T15:38:31+00:00",
  "version": "2015-08-06",
  "stratum_id": "100",
  "description": "This TA is used by Cuke Test",
  "target_id": "113",
  "target_name": "Crizotinib",
  "func_gene": "ALK",
  "treatment_arm_status": "OPEN",
  "study_id": "APEC1621",
  "assay_rules": [],
  "num_patients_assigned": null,
  "treatment_arm_drugs": [{
    "name": "Crizotinib",
    "pathway": "ALK",
    "drug_id": "113"
  }],
  "snv_indels": [],

  "non_hotspot_rules": [{
    "inclusion": true,
    "oncomine_variant_class": "deleterious",
    "public_med_ids": [],
    "func_gene": "PTEN",
    "arm_specific": false,
    "level_of_evidence": 3.0,
    "function": null,
    "protein_match": null,
    "type": "nhr",
    "exon": null
  }],
  "copy_number_variants": [],
  "gene_fusions": [{
    "ocp_reference": "A",
    "gene_name": "ALK",
    "identifier": "TPM3-ALK.T7A20",
    "inclusion": true,
    "public_med_ids": ["23724913"],
    "arm_specific": false,
    "level_of_evidence": 2.0,
    "chromosome": "chr2",
    "ocp_alternative": "[chr1:154142875[A",
    "description": "ALK translocation",
    "position": "29446394",
    "type": "gf"
  }, {
    "ocp_reference": "C",
    "gene_name": "FGFR2",
    "identifier": "FGFR2-OFD1.F17O3",
    "inclusion": true,
    "public_med_ids": [],
    "arm_specific": false,
    "level_of_evidence": 3.0,
    "chromosome": "chr10",
    "ocp_alternative": "C[chrX:13754596[",
    "description": "some description",
    "position": "123243211",
    "type": "gf"
  }],
  "exclusion_diseases": [{
    "disease_code_type":"ICD-O",
    "disease_code": "10058354",
    "disease_name": "Bronchioloalveolar carcinoma",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "10025032",
    "disease_name": "Lung adenocarcinoma",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "90600324",
    "disease_name": "Lung adenocar. w/ bronch. feat.",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "10029514",
    "disease_name": "Non-small cell lung cancer, NOS",
    "exclusion":true
  }, {
    "disease_code_type":"ICD-O",
    "disease_code": "10025125",
    "disease_name": "Squamous cell lung carcinoma",
    "exclusion":true
  },{
    "disease_code_type":"ICD-O",
    "disease_code": "10033701",
    "disease_name": "Papillary thyroid carcinoma",
    "exclusion":false
  }],
  "exclusion_drugs": [{
    "name": "Doxorubicin Hydrochloride",
    "drug_id": "10001",
    "drug_class": "ALK inhibitor",
    "target": "ALK"
  }],
  "status_log": [],
  "current_patients": "0.0",
  "former_patients": "0.0",
  "not_enrolled_patients": "0.0",
  "pending_patients": "0.0"
}, {
  "active": true,
  "name": "Rules-Test3",
  "date_created": "2016-06-24T15:38:31+00:00",
  "version": "2015-08-06",
  "stratum_id": "100",
  "description": "This TA is used by Cuke Test",
  "target_id": "113",
  "target_name": "Crizotinib",
  "func_gene": "ALK",
  "treatment_arm_status": "OPEN",
  "study_id": "APEC1621",
  "assay_rules": [],
  "num_patients_assigned": null,
  "treatment_arm_drugs": [{
    "name": "Crizotinib",
    "pathway": "ALK",
    "drug_id": "113"
  }],
  "snv_indels": [],

  "non_hotspot_rules": [{
    "inclusion": true,
    "oncomine_variant_class": "hotspot",
    "public_med_ids": [],
    "func_gene": "KIT",
    "arm_specific": false,
    "level_of_evidence": 3.0,
    "function": "missense",
    "protein_match": null,
    "type": "nhr",
    "exon": "20"
  }],
  "copy_number_variants": [],
  "diseases": [{
    "disease_code_type":"ICD-O",
    "disease_code": "10058354",
    "disease_name": "Bronchioloalveolar carcinoma",
    "exclusion":true
    },
    {
    "disease_code_type":"ICD-O",
    "disease_code": "10033701",
    "disease_name": "Papillary thyroid carcinoma",
    "exclusion":false
   }],
  "exclusion_drugs": [{
    "name": "Doxorubicin Hydrochloride",
    "drug_id": "10001",
    "drug_class": "ALK inhibitor",
    "target": "ALK"
  }],
  "status_log": [],
  "current_patients": "0.0",
  "former_patients": "0.0",
  "not_enrolled_patients": "0.0",
  "pending_patients": "0.0"
}]